CoQ10 (ubiquinol vs ubiquinone)
Summary
CoQ10 is sold as ubiquinone (oxidized) or ubiquinol (reduced). In a 12-person comparison, ubiquinol raised blood CoQ10 more (grade D). Statins lower blood CoQ10, but trials of CoQ10 for statin muscle symptoms disagree (grade C), and it had no clear effect on blood pressure. NCCIH reports only mild side effects.
Key facts
How it works
ProposedCoQ10 is a cofactor for cellular energy production and an antioxidant (established physiology). Trials show statins lower circulating CoQ10; whether this contributes to statin-associated muscle symptoms is proposed, not established.[7][6]
What the human research says
Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.
At a glance: strongest evidence per outcome
| Outcome | Grade | Effect | Strongest evidence | Rows |
|---|---|---|---|---|
| Heart | Grade C | Mixed | Meta-analysis · n = 575 · 2018 | 3 rows |
| Energy | Grade D | Improved | Open-label · n = 12 · 2014 | 1 row |
Every graded row
| Outcome | Effect | Grade | Best evidence | PMID |
|---|---|---|---|---|
| Muscle symptoms in statin users | Mixed | Grade C | Meta-analysis · n = 575 · 2018 12 RCTs (575 patients) of CoQ10 for statin-associated muscle symptoms Form: CoQ10 (form not specified in abstract) · Dose: Varied across trials · Duration: Varied across trials CoQ10 reduced muscle pain, weakness, cramps and tiredness scores versus placebo; creatine kinase did not change. | 30371340 (opens PubMed)Source [3] |
| Long-term clinical events (heart-failure trial) | Improved | Grade C | RCT · n = 420 · 2014 Adults with moderate to severe chronic heart failure on standard therapy (Q-SYMBIO) Form: coenzyme Q10 · Dose: 100 mg three times daily (300 mg/day) · Duration: 2 years No change in the 16-week endpoints. At 2 years, major adverse cardiovascular events occurred in 15% vs 26% (HR 0.50); cardiovascular and all-cause mortality and heart-failure hospital stays were also lower. | 25282031 (opens PubMed)Source [6] |
| Blood pressure | No effect | Grade C | Meta-analysis · n = 50 · 2016 2 double-blind RCTs in adults with primary hypertension Form: coenzyme Q10 · Dose: Varied across trials · Duration: At least 3 weeks No significant change in systolic (-3.68 mm Hg) or diastolic (-2.03 mm Hg) blood pressure; authors judged the evidence moderate quality for no clinically significant effect. | 26935713 (opens PubMed)Source [5] |
| Blood CoQ10 levels: ubiquinol vs ubiquinone | Improved | Grade D | Open-label trial · n = 12 · 2014 Healthy volunteers Form: ubiquinol vs ubiquinone (identical softgel excipients) · Dose: 200 mg/day of each, in sequence · Duration: 4 weeks each, with a 4-week washout Plasma total CoQ10 rose from 0.9 to 4.3 µg/mL with ubiquinol versus 0.9 to 2.5 µg/mL with ubiquinone; the increase was significantly larger with ubiquinol. No side effects noted. | 27128225 (opens PubMed)Source [2] |
Forms
| Form | Elemental % | Absorption (human data) | GI tolerance | Studied for |
|---|---|---|---|---|
| Ubiquinone (oxidized CoQ10) | Varies[8] | Raised plasma CoQ10 less than ubiquinol in one 12-person comparison.[2] | Mild insomnia or digestive upset may occur; no serious side effects reported.[1] | Outcome trials (form not stated in the outcome-trial abstracts graded here) |
| Ubiquinol (reduced CoQ10) | Varies[8] | Higher plasma total CoQ10 than ubiquinone at 200 mg/day for 4 weeks (4.3 vs 2.5 µg/mL) in one small study.[2] | No side effects noted in the comparison study.[2] | Blood CoQ10 levels (bioavailability) |
Studied doses
Doses studied in human trials ranged from 200 to 300 mg/day of CoQ10 in the trials graded here, for 4 weeks to 2 years. Doses in the pooled statin and blood-pressure trials are not reported in the meta-analysis abstracts.[2][6]
Interactions
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Medicines
Medicines that can lower levels
- StatinsRCTA meta-analysis of 12 RCTs (n=1,776) found statins lowered circulating CoQ10, regardless of statin type, intensity or treatment length.[7]
Who should be careful
- People on warfarin or insulin
- NCCIH lists possible interactions with warfarin and insulin; dose changes of those medicines may need monitoring.[1]
- People in cancer treatment
- NCCIH notes CoQ10 may not be compatible with some cancer treatments.[1]
- Pregnancy and breastfeeding
- Insufficient safety data in our sources.[1]
- Side effects
- No serious side effects reported; mild insomnia or digestive upset may occur.[1]
- Before you start
- Talk to your pharmacist or clinician before adding this supplement, especially if you take prescription medicines, are pregnant or breastfeeding, or have a chronic health condition.[1]
Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.
Articles about CoQ10 (ubiquinol vs ubiquinone)
Plain-English answers to common questions, built on the evidence above.
Frequently asked questions
Is ubiquinol better than ubiquinone?
Ubiquinol raised blood CoQ10 more in one small study: 4.3 vs 2.5 µg/mL after 4 weeks at 200 mg/day in 12 healthy adults. The study was not randomized, and no trials show ubiquinol produces better health outcomes than ubiquinone.[2]
Should statin users consider CoQ10?
Statins lower blood CoQ10 in trials, but evidence on muscle symptoms conflicts: one meta-analysis of 12 trials found lower muscle-symptom scores, while another of 7 trials found no benefit. NCCIH concludes the overall evidence does not support a benefit. Discuss muscle symptoms with your prescriber.[7][3][4][1]
Does CoQ10 lower blood pressure?
Probably not meaningfully. A Cochrane review found no significant change in blood pressure, though only 50 participants could be pooled; NCCIH reaches the same conclusion.[5][1]
What are the side effects of CoQ10?
NCCIH reports no serious side effects. Mild insomnia or digestive upset may occur. It may interact with warfarin and insulin.[1]
Sources
- [1]Coenzyme Q10. National Center for Complementary and Integrative Health (NCCIH), 2019. fact-sheet
- [2]Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone.. Clin Pharmacol Drug Dev, 2014. open-label
- [3]Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.. J Am Heart Assoc, 2018. meta-analysis
- [4]Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis.. Atherosclerosis, 2020. meta-analysis
- [5]Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.. Cochrane Database Syst Rev, 2016. meta-analysis
- [6]The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.. JACC Heart Fail, 2014. RCT
- [7]The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials.. Eur J Med Res, 2018. meta-analysis
- [8]Ubiquinone-10 (CID 5281915) and ubiquinol (CID 9962735): molecular weights. PubChem, NCBI, 2026. database
What changed
- First draft. Every evidence-row PMID checked with NCBI E-utilities (esummary + efetch abstract) and re-read in an independent adversarial pass.
